A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp
Clinical trial NCT02611804 · COMPLETED
Trial details
- NCT number
- NCT02611804
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-08-01
- Enrollment
- 492
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.